Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-06-22

Clinical Trial Update: Multi-Center, Prospective, Randomized, Comparison of AWBAT™-D vs. Xeroform™ or Glucan II™ for Treatment of Donor Sites in Burn Surgery [NA]

View source ↗

Summary

Clinical trial update comparing AWBAT-D with Xeroform or Glucan II for treatment of donor-site burns in burn surgery; current trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AWBAT-D
  • Glucan II
  • Xeroform

Snippet

Sponsor: Aubrey Inc. | Conditions: Treatment of Donor Site Burns | NA | Status: UNKNOWN